ENTRY       D02106                      Drug
NAME        Arsenic trioxide (JP18/USAN);
            Trisenox (TN)
PRODUCT     TRISENOX (Cephalon)
  GENERIC   ARSENIC TRIOXIDE (Amneal Pharmaceuticals LLC)
            ARSENIC TRIOXIDE (Amring Pharmaceuticals)
            ARSENIC TRIOXIDE (Athenex Pharmaceutical Division)
            ARSENIC TRIOXIDE (AuroMedics Pharma LLC)
            ARSENIC TRIOXIDE (Fresenius Kabi USA)
            ARSENIC TRIOXIDE (Gland Pharma Limited)
            ARSENIC TRIOXIDE (Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals)
            ARSENIC TRIOXIDE (Ingenus Pharmaceuticals)
            ARSENIC TRIOXIDE (Nexus Pharmaceuticals)
            ARSENIC TRIOXIDE (Orbicular Pharmaceutical Technologies Private Limited)
            ARSENIC TRIOXIDE (STI Pharma LLC)
            ARSENIC TRIOXIDE (Sagent Pharmaceuticals)
            ARSENIC TRIOXIDE (Sandoz)
            ARSENIC TRIOXIDE (Zydus Lifesciences Limited)
            ARSENIC TRIOXIDE (Zydus Lifesciences Limited)
            ARSENIC TRIOXIDE (Zydus Pharmaceuticals USA)
            ARSENIC TRIOXIDE (Zydus Pharmaceuticals USA)
            ARSENIC TRIOXIDE (Zydus Pharmaceuticals USA)
            ARSENIC TRIOXIDE (Zydus Pharmaceuticals USA)
FORMULA     As2O3
EXACT_MASS  197.8279
MOL_WEIGHT  197.8414
REMARK      Same as: C13619
            Therapeutic category: 4291
            ATC code: L01XX27
            Product: D02106<JP/US>
EFFICACY    Antineoplastic
  DISEASE   Acute promyelocytic leukemia [DS:H02542]
TARGET      PML-RARA [HSA:5371 5914] [KO:K10054 K08527]
  PATHWAY   hsa05200(5371+5914)  Pathways in cancer
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX27 Arsenic trioxide
                  D02106  Arsenic trioxide (JP18/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antineoplastics, Other
               Arsenic Trioxide
                D02106  Arsenic trioxide (JP18/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D02106  Arsenic trioxide (JP18/USAN)
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Thyroid hormone like receptors
               Retinoic acid receptor (RAR)
                PML-RARA
                 D02106  Arsenic trioxide (JP18/USAN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D02106  Arsenic trioxide
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02106
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02106
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02106
DBLINKS     CAS: 1327-53-3
            PubChem: 7849167
            ChEBI: 30621 49900
            NIKKAJI: J44.421I
///
